Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8469226rdf:typepubmed:Citationlld:pubmed
pubmed-article:8469226lifeskim:mentionsumls-concept:C0025149lld:lifeskim
pubmed-article:8469226lifeskim:mentionsumls-concept:C0008625lld:lifeskim
pubmed-article:8469226lifeskim:mentionsumls-concept:C0008626lld:lifeskim
pubmed-article:8469226lifeskim:mentionsumls-concept:C0205221lld:lifeskim
pubmed-article:8469226pubmed:issue4lld:pubmed
pubmed-article:8469226pubmed:dateCreated1993-5-10lld:pubmed
pubmed-article:8469226pubmed:abstractTextA 3-year-old girl developed central nervous system, bone and bone marrow metastases, and hypercalcaemia shortly after presentation with medulloblastoma. Cytogenetic studies of the involved bone marrow showed multiple abnormalities including iso(17q). This chromosome rearrangement has been reported in other cases of recurrent or disseminated medulloblastoma. More studies are required relating the karyotypes of medulloblastomas to long-term outcome to determine if the presence of iso(17q) is a prognostic factor in this malignancy.lld:pubmed
pubmed-article:8469226pubmed:languageenglld:pubmed
pubmed-article:8469226pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8469226pubmed:citationSubsetIMlld:pubmed
pubmed-article:8469226pubmed:statusMEDLINElld:pubmed
pubmed-article:8469226pubmed:issn0098-1532lld:pubmed
pubmed-article:8469226pubmed:authorpubmed-author:PerryR HRHlld:pubmed
pubmed-article:8469226pubmed:authorpubmed-author:PearsonA DADlld:pubmed
pubmed-article:8469226pubmed:authorpubmed-author:CrawfordP JPJlld:pubmed
pubmed-article:8469226pubmed:authorpubmed-author:DavisonE VEVlld:pubmed
pubmed-article:8469226pubmed:authorpubmed-author:EmslieJJlld:pubmed
pubmed-article:8469226pubmed:authorpubmed-author:LennardAAlld:pubmed
pubmed-article:8469226pubmed:authorpubmed-author:StuartA GAGlld:pubmed
pubmed-article:8469226pubmed:issnTypePrintlld:pubmed
pubmed-article:8469226pubmed:volume21lld:pubmed
pubmed-article:8469226pubmed:ownerNLMlld:pubmed
pubmed-article:8469226pubmed:authorsCompleteYlld:pubmed
pubmed-article:8469226pubmed:pagination295-8lld:pubmed
pubmed-article:8469226pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8469226pubmed:meshHeadingpubmed-meshheading:8469226-...lld:pubmed
pubmed-article:8469226pubmed:meshHeadingpubmed-meshheading:8469226-...lld:pubmed
pubmed-article:8469226pubmed:meshHeadingpubmed-meshheading:8469226-...lld:pubmed
pubmed-article:8469226pubmed:meshHeadingpubmed-meshheading:8469226-...lld:pubmed
pubmed-article:8469226pubmed:meshHeadingpubmed-meshheading:8469226-...lld:pubmed
pubmed-article:8469226pubmed:meshHeadingpubmed-meshheading:8469226-...lld:pubmed
pubmed-article:8469226pubmed:meshHeadingpubmed-meshheading:8469226-...lld:pubmed
pubmed-article:8469226pubmed:meshHeadingpubmed-meshheading:8469226-...lld:pubmed
pubmed-article:8469226pubmed:meshHeadingpubmed-meshheading:8469226-...lld:pubmed
pubmed-article:8469226pubmed:meshHeadingpubmed-meshheading:8469226-...lld:pubmed
pubmed-article:8469226pubmed:year1993lld:pubmed
pubmed-article:8469226pubmed:articleTitleCytogenetic abnormalities in a disseminated medulloblastoma.lld:pubmed
pubmed-article:8469226pubmed:affiliationDepartment of Child Health, University of Newcastle Upon Tyne, England.lld:pubmed
pubmed-article:8469226pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8469226pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:8469226pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed